How big is the Asia-Pacific Blood Glucose Monitoring Market?

FEB 2023: Dexcom G6 Continuous Glucose Monitoring System was launched in Singapore.
MAR 2022: Quantum Operation Inc., a Tokyo-based healthcare IoT startup, presented the world's first non-invasive glucose monitor capable of continuous measurement. It measures the blood sugar from the wrist without any pricks.

The Asia-Pacific Blood Glucose Monitoring Market size is expected to reach USD 3.77 billion in 2024 and grow at a CAGR of 7.69% to reach USD 5.54 billion by 2029. Read More

What is the current Asia-Pacific Blood Glucose Monitoring Market size?

In 2024, the Asia-Pacific Blood Glucose Monitoring Market size is expected to reach USD 3.77 billion. Read More

Who are the key players in Asia-Pacific Blood Glucose Monitoring Market?

Roche, Medtronics, Dexcom, Abbott Diabetes Care and Johnson & Johnson are the major companies operating in the Asia-Pacific Blood Glucose Monitoring Market. Read More

What years does this Asia-Pacific Blood Glucose Monitoring Market cover, and what was the market size in 2023?

In 2023, the Asia-Pacific Blood Glucose Monitoring Market size was estimated at USD 3.5 billion. The report covers the Asia-Pacific Blood Glucose Monitoring Market historical market size for years: 2018, 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Asia-Pacific Blood Glucose Monitoring Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Asia-Pacific Blood Glucose Monitoring Companies

This report lists the top Asia-Pacific Blood Glucose Monitoring companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Asia-Pacific Blood Glucose Monitoring industry.